We have built our business from scratch in close partnership with L2S2. Their approach is solutions-driven and highly creative but combined with a level of quality, reliability and resilience that is unrivalled, with the result that we benefit from very high levels of client satisfaction in an extremely demanding niche market. Over the years, L2S2 have consistently provided the innovation, technology and support that have allowed us to become leaders in our field in the UK and overseas. Most recently, Xenplate has allowed us to launch our new COMPASS risk-adjusted outcomes predictor into the medical market in record time.
L2S2 develop and host our LungHealth 'Guided Consultation' software for COPD that combines patient management, data collection and performance monitoring used in GP practices in the UK. Their ability to interface to TPP SystmOne and EMIS is critical to our success in this field.